Quality of life in pediatric heart transplant recipients: A comparison with children with and without heart disease

被引:53
|
作者
Uzark, Karen [1 ]
Griffin, Lisa [2 ]
Rodriguez, Rose [3 ]
Zamberlan, Meg [4 ]
Murphy, Paula [5 ]
Nasman, Colleen [6 ]
Dupuis, Joanne [7 ]
Rodgers, Sherrie [8 ]
Limbers, Christine A. [9 ]
Varni, James W. [10 ]
机构
[1] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
[2] Loma Linda Univ, Loma Linda, CA 92350 USA
[3] Columbia Univ, Med Ctr, New York, NY USA
[4] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
[5] St Louis Childrens Hosp, St Louis, MO 63178 USA
[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[7] Childrens Hosp Michigan, Detroit, MI 48201 USA
[8] Childrens Mem Hosp, Chicago, IL 60614 USA
[9] Baylor Univ, Waco, TX 76798 USA
[10] Texas A&M Univ, College Stn, TX USA
来源
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2012年 / 31卷 / 06期
关键词
pediatric heart transplant; quality of life; psychosocial impact; congenital heart disease; transplant outcomes; children; LUNG TRANSPLANTATION; BEHAVIORAL STATUS; MEDICAL SEVERITY; ORGAN TRANSPLANT; IMPACT; PEDSQL(TM)-4.0; RELIABILITY; VALIDITY; STRESS;
D O I
10.1016/j.healun.2012.01.867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Little is known about the quality of life (QOL) of children with heart disease who undergo life-saving surgery. The aim of this multicenter study was to examine self- and parent-reported QOL outcomes in pediatric heart transplant recipients. METHODS: Pediatric heart transplant recipients/families (n = 174) from 7 transplant programs completed the Pediatric Quality of Life Inventory Generic Core Scales and Cardiac Module. Scores for the heart transplant sample were compared with non-transplant patients who had undergone conventional cardiac surgery and with a healthy child sample. Within the cardiac surgery group, heart disease/surgery was further categorized by severity/complexity. RESULTS: Heart transplant recipients were a mean age of 10.6 +/- 4.7 years at a mean time post-transplant of 6.0 +/- 4.1 years. By both self-report and parent proxy report, mean scores for heart transplant recipients were significantly lower than those in healthy children for physical and psychosocial QOL, including emotional and social functioning (p < 0.001), with 31.3% self-reporting significantly impaired psychosocial QOL scores. By self-report, there were no significant differences in emotional and social mean scores between the transplant and cardiac surgery groups. Transplant recipients reported significantly fewer cardiac symptoms than children with cardiac surgery (p < 0.01). Their self-reported school functioning scores were not significantly different from children with moderate to severe disease. CONCLUSION: Although pediatric heart transplant recipients experience significant symptomatic improvement, they remain at-risk for impaired psychosocial QOL, similar to children with residual or palliated heart disease. Assessment is needed to identify children at-risk and improve psychosocial outcomes. Heart Lung Transplant 2012;31:571-8 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:571 / 578
页数:8
相关论文
共 50 条
  • [41] Catheter Interventions in Pediatric Heart Transplant Recipients
    Blackstone, W. Z.
    Malaguit, S. E.
    Frandsen, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 382 - 382
  • [42] Hemorrhagic Pancreatitis in Pediatric Heart Transplant Recipients
    Schwietert, M.
    Nunez, D. Sanabria
    Petty, D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S32 - S33
  • [43] The Quilty Effect in Pediatric Heart Transplant Recipients
    Joong, A.
    Richmond, M. E.
    Stack, K. O.
    Rodriguez, R. J.
    McAllister, J. M.
    Zuckerman, Wa.
    Lee, T. M.
    Law, S.
    Addonizio, L. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S75 - S75
  • [44] Neurodevelopmental outcomes in pediatric heart transplant recipients
    Uzark, K.
    Slusher, J.
    Beebe, D.
    Spicer, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S148 - S148
  • [45] Treatment of hyperhomocysteinemia in pediatric heart transplant recipients
    Parisi, F
    Danesi, H
    Di Ciommo, V
    Fina, F
    Giannone, G
    Colistro, F
    Di Donato, RM
    Catena, G
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (07): : 778 - 783
  • [46] Neurodevelopmental Outcomes in Pediatric Heart Transplant Recipients
    Uzark, Karen
    Spicer, Robert
    Beebe, Dean W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (12): : 1306 - 1311
  • [47] Masked Hypertension in Pediatric Heart Transplant Recipients
    Neha Bansal
    Waheed A. Raedi
    Shivanand S. Medar
    Lincy Abraham
    Kimberly Beddows
    Daphne T. Hsu
    Jacqueline M. Lamour
    Joseph Mahgerefteh
    Pediatric Cardiology, 2023, 44 : 1003 - 1008
  • [48] Alloantibody reduction in pediatric heart transplant recipients
    Rose-Felker, Kirsten
    Zinn, Matthew
    West, Shawn C.
    Miller, Susan A.
    Magnetta, Defne
    Mangiola, Massimo
    Zeevi, Adriana
    Feingold, Brian D.
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [49] Coronary ectasia in pediatric heart transplant recipients
    Kaufman, BD
    Hsu, DT
    Torres, A
    Hellenbrand, WE
    Lamour, JM
    Pass, RH
    Korsin, R
    Addonizio, LJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 486A - 486A
  • [50] Monotherapy Immunosuppression in Pediatric Heart Transplant Recipients
    Profita, E. L.
    Lee, D.
    Barkoff, L.
    Lee, J.
    Chen, C.
    Dykes, J. C.
    Hollander, S. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S507 - S507